Research ExplorerJournalsCLIN CANCER RES Publications

CLIN CANCER RES

51 - 100 out of 126Page size: 50

Publications

  1. 2014

  2. ABO blood group IgM isoagglutinins interact with tumor-associated O-glycan structures in pancreatic cancer

    Hofmann, B. T., Stehr, A., Dohrmann, T., Güngör, C., Herich, L., Hiller, J., Harder, S., Ewald, F., Gebauer, F., Tachezy, M., Precht, C., Izbicki, J. R., Bockhorn, M., Wagener, C. & Wolters-Eisfeld, G., 2014, In: CLIN CANCER RES. 20, 23, p. 6117-26 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  3. Prognostic relevance of circulating tumor cells in blood and disseminated tumor cells in bone marrow of patients with squamous cell carcinoma of the oral cavity

    Gröbe, A., Blessmann, M., Hanken, H., Friedrich, R. E., Schön, G., Wikner, J., Harms-Effenberger, K., Kluwe, L., Heiland, M., Pantel, K. & Riethdorf, S., 2014, In: CLIN CANCER RES. 20, 2, p. 425-33 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  4. 2013

  5. Long-term survival in primary glioblastoma with versus without isocitrate dehydrogenase mutations

    Hartmann, C., Hentschel, B., Simon, M., Westphal, M., Schackert, G., Tonn, J. C., Loeffler, M., Reifenberger, G., Pietsch, T., von Deimling, A., Weller, M. & German Glioma Network, 15.09.2013, In: CLIN CANCER RES. 19, 18, p. 5146-57 12 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  6. Ki67 measured after neoadjuvant chemotherapy for primary breast cancer

    von Minckwitz, G., Schmitt, W. D., Loibl, S., Müller, B. M., Blohmer, J. U., Sinn, B. V., Eidtmann, H., Eiermann, W., Gerber, B., Tesch, H., Hilfrich, J., Huober, J., Fehm, T., Barinoff, J., Rüdiger, T., Erbstoesser, E., Fasching, P. A., Karn, T., Müller, V., Jackisch, C. & Denkert, C., 15.08.2013, In: CLIN CANCER RES. 19, 16, p. 4521-31 11 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  7. High phospho-Stathmin(Serine38) expression identifies aggressive endometrial cancer and suggests an association with PI3K inhibition

    Wik, E., Birkeland, E., Trovik, J., Werner, H. M. J., Hoivik, E. A., Mjos, S., Krakstad, C., Kusonmano, K., Mauland, K., Stefansson, I. M., Holst, F., Petersen, K., Oyan, A. M., Simon, R., Kalland, K. H., Ricketts, W., Akslen, L. A. & Salvesen, H. B., 01.05.2013, In: CLIN CANCER RES. 19, 9, p. 2331-41 11 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  8. 2012

  9. The relationship between homologous recombination repair and the sensitivity of human epidermis to the size of daily doses over a 5-week course of breast radiotherapy

    Somaiah, N., Yarnold, J., Daley, F., Pearson, A., Gothard, L., Rothkamm, K. & Helleday, T., 01.10.2012, In: CLIN CANCER RES. 18, 19, p. 5479-88 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  10. A comprehensive analysis of human gene expression profiles identifies stromal immunoglobulin κ C as a compatible prognostic marker in human solid tumors.

    Schmidt, M., Hellwig, B., Hammad, S., Othman, A., Lohr, M., Chen, Z., Boehm, D., Gebhard, S., Petry, I., Lebrecht, A., Cadenas, C., Marchan, R., Stewart, J. D., Solbach, C., Holmberg, L., Edlund, K., Kultima, H. G., Rody, A., Berglund, A., Lambe, M., Isaksson, A., Botling, J., Karn, T., Müller, V., Gerhold-Ay, A., Cotarelo, C., Sebastian, M., Kronenwett, R., Bojar, H., Lehr, H-A., Sahin, U., Koelbl, H., Gehrmann, M., Micke, P., Rahnenführer, J. & Hengstler, J. G., 2012, In: CLIN CANCER RES. 18, 9, p. 2695-2703 9.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  11. Changes in keratin expression during metastatic progression of breast cancer: impact on the detection of circulating tumor cells.

    Joosse, S., Hannemann, J., Spötter, J., Bauche, A., Andreas, A., Müller, V. & Pantel, K., 2012, In: CLIN CANCER RES. 18, 4, p. 993-1003 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  12. Circulating miRNAs as surrogate markers for circulating tumor cells and prognostic markers in metastatic breast cancer.

    Madhavan, D., Zucknick, M., Wallwiener, M., Cuk, K., Modugno, C., Scharpff, M., Schott, S., Heil, J., Turchinovich, A., Yang, R., Benner, A., Riethdorf, S., Trumpp, A., Sohn, C., Pantel, K., Schneeweiss, A. & Burwinkel, B., 2012, In: CLIN CANCER RES. 18, 21, p. 5972-5982 21.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  13. Glioblastoma stem-like cell lines with either maintenance or loss of high-level EGFR amplification, generated via modulation of ligand concentration.

    Schulte, A., Günther, H., Martens, T., Zapf, S., Riethdorf, S., Wülfing, C., Stoupiec, M., Westphal, M. & Lamszus, K., 2012, In: CLIN CANCER RES. 18, 7, p. 1901-1913 7.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  14. Human prostate cancer in a clinically relevant xenograft mouse model: identification of β(1,6)-branched oligosaccharides as a marker of tumor progression.

    Lange, T., Ullrich, S., Müller, I., Nentwich, M., Stübke, K., Feldhaus, S., Knies, C., Hellwinkel, O., Vessella, R. L., Abramjuk, C., Anders, M., Schröder-Schwarz, J., Schlomm, T., Huland, H., Sauter, G. & Schumacher, U., 2012, In: CLIN CANCER RES. 18, 5, p. 1364-1373 5.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  15. Loss of heterozygosity at tumor suppressor genes detectable on fractionated circulating cell-free tumor DNA as indicator of breast cancer progression.

    Schwarzenbach, H., Eichelser, C., Kropidlowski, J., Janni, W., Rack, B. & Pantel, K., 2012, In: CLIN CANCER RES. 18, 20, p. 5719-5730 20.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  16. Meta-analysis of the prognostic value of circulating tumor cells in breast cancer.

    Zhang, L., Riethdorf, S., Wu, G., Wang, T., Yang, K., Peng, G., Liu, J. & Pantel, K., 2012, In: CLIN CANCER RES. 18, 20, p. 5701-5710 20.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  17. Targeting aurora kinases with danusertib (PHA-739358) inhibits growth of liver metastases from gastroenteropancreatic neuroendocrine tumors in an orthotopic xenograft model.

    Fraedrich, K., Schrader, J., Ittrich, H., von Amsberg, G., Gontarewicz, A., Matzat, V., Kromminga, A., Pace, A., Moll, J., Bläker, M., Lohse, A. W., Hörsch, D., Brümmendorf, T. & Benten, D., 2012, In: CLIN CANCER RES. 18, 17, p. 4621-4632 17.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  18. 2011

  19. Expression of FoxM1 is required for the proliferation of medulloblastoma cells and indicates worse survival of patients

    Priller, M., Pöschl, J., Abrão, L., von Bueren, A. O., Cho, Y-J., Rutkowski, S., Kretzschmar, H. A. & Schüller, U., 01.11.2011, In: CLIN CANCER RES. 17, 21, p. 6791-801 11 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  20. A new molecular predictor of distant recurrence in ER-positive, HER2-negative breast cancer adds independent information to conventional clinical risk factors.

    Filipits, M., Rudas, M., Jakesz, R., Dubsky, P., Fitzal, F., Singer, C. F., Dietze, O., Greil, R., Jelen, A., Sevelda, P., Freibauer, C., Müller, V., Jänicke, F., Schmidt, M., Kölbl, H., Rody, A., Kaufmann, M., Schroth, W., Brauch, H., Schwab, M., Fritz, P., Weber, K. E., Feder, I. S., Hennig, G., Kronenwett, R., Gehrmann, M., Gnant, M. & Investigators, EP., 2011, In: CLIN CANCER RES. 17, 18, p. 6012-6020 18.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  21. Biomarkers for cetuximab-based neoadjuvant radiochemotherapy in locally advanced rectal cancer.

    Grimminger, P. P., Danenberg, P., Dellas, K., Arnold, D., Rödel, C., Machiels, J-P., Haustermans, K., Debucquoy, A., Velenik, V., Sempoux, C., Bracko, M., Hölscher, A. H., Semrau, R., Yang, D., Danenberg, K., Lenz, H-J. & Vallböhmer, D., 2011, In: CLIN CANCER RES. 17, 10, p. 3469-3477 10.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  22. EGF61 polymorphism predicts complete pathologic response to cetuximab-based chemoradiation independent of KRAS status in locally advanced rectal cancer patients.

    Hu-Lieskovan, S., Vallbohmer, D., Zhang, W., Yang, D., Pohl, A., Labonte, M. J., Grimminger, P. P., Hölscher, A. H., Semrau, R., Arnold, D., Dellas, K., Debucquoy, A., Haustermans, K., Machiels, J-P. H., Sempoux, C., Rödel, C., Bracko, M., Velenik, V. & Lenz, H-J., 2011, In: CLIN CANCER RES. 17, 15, p. 5161-5169 15.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  23. ERG status is unrelated to PSA recurrence in radically operated prostate cancer in the absence of antihormonal therapy.

    Minner, S. J. P., Enodien, M., Sirma, H., Lübke, A., Krohn, A., Mayer, P. S., Simon, R., Tennstedt, P., Müller, J., Scholz, L., Brase, J. C., Liu, A. Y., Schlüter, H., Pantel, K., Schumacher, U., Bokemeyer, C., Steuber, T., Graefen, M., Sauter, G. & Schlomm, T., 2011, In: CLIN CANCER RES. 17, 18, p. 5878-5888 18.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  24. Persistence of disseminated tumor cells in the bone marrow of breast cancer patients predicts increased risk for relapse--a European pooled analysis.

    Janni, W., Vogl, F. D., Wiedswang, G., Synnestvedt, M., Fehm, T., Jückstock, J., Borgen, E., Rack, B., Braun, S., Sommer, H., Solomayer, E., Pantel, K., Nesland, J., Friese, K. & Naume, B., 2011, In: CLIN CANCER RES. 17, 9, p. 2967-2976 9.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  25. The histone methyltransferase and putative oncoprotein MMSET is overexpressed in a large variety of human tumors.

    Hudlebusch, H. R., Santoni-Rugiu, E., Simon, R., Ralfkiær, E., Rossing, H. H., Johansen, J. V., Jørgensen, M., Sauter, G. & Helin, K., 2011, In: CLIN CANCER RES. 17, 9, p. 2919-2933 9.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  26. 2010

  27. BRCA1 loss preexisting in small subpopulations of prostate cancer is associated with advanced disease and metastatic spread to lymph nodes and peripheral blood

    Bednarz, N., Eltze, E., Semjonow, A., Rink, M., Andreas, A., Mulder, L., Hannemann, J., Fisch, M., Pantel, K., Weier, H-U. G., Bielawski, K. P. & Brandt, B., 2010, In: CLIN CANCER RES. 16, 13, p. 3340-3348 9 p., 13.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  28. Chromosome 8p deletions and 8q gains are associated with tumor progression and poor prognosis in prostate cancer.

    El Gammal, A. T., Brüchmann, M., Zustin, J., Isbarn, H., Hellwinkel, O., Köllermann, J., Sauter, G., Simon, R., Wilczak, W., Schwarz, J., Bokemeyer, C., Brümmendorf, T., Izbicki, J. R., Yekebas, E. F., Fisch, M., Huland, H., Graefen, M. & Schlomm, T., 2010, In: CLIN CANCER RES. 16, 1, p. 56-64 1.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  29. Detection and HER2 expression of circulating tumor cells: prospective monitoring in breast cancer patients treated in the neoadjuvant GeparQuattro trial.

    Riethdorf, S., Müller, V., Zhang, L., Rau, T., Loibl, S., Komor, M., Roller, M., Huober, J., Fehm, T., Schrader, I., Hilfrich, J., Holms, F., Tesch, H., Eidtmann, H., Untch, M., von Minckwitz, G. & Pantel, K., 2010, In: CLIN CANCER RES. 16, 9, p. 2634-2645 9.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  30. Dietary curcumin attenuates glioma growth in a syngeneic mouse model by inhibition of the JAK1,2/STAT3 signaling pathway.

    Weissenberger, J., Priester, M., Bernreuther, C., Rakel, S., Glatzel, M., Seifert, V. & Kögel, D., 2010, In: CLIN CANCER RES. 16, 23, p. 5781-5795 23.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  31. Gene expression analysis identifies potential biomarkers of neurofibromatosis type 1 including adrenomedullin.

    Hummel, T. R., Jessen, W. J., Miller, S. J., Kluwe, L., Mautner, V. F., Wallace, M. R., Lázaro, C., Page, G. P., Worley, P. F., Aronow, B. J., Schorry, E. K. & Ratner, N., 2010, In: CLIN CANCER RES. 16, 20, p. 5048-5057 20.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  32. Low level HER2 overexpression is associated with rapid tumor cell proliferation and poor prognosis in prostate cancer.

    Minner, S. J. P., Jessen, B., Stiedenroth, L., Burandt, E. C., Köllermann, J., Mirlacher, M., Erbersdobler, A., Eichelberg, C., Fisch, M., Brümmendorf, T., Bokemeyer, C., Simon, R., Steuber, T., Graefen, M., Huland, H., Sauter, G. & Schlomm, T., 2010, In: CLIN CANCER RES. 16, 5, p. 1553-1560 5.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  33. Phase I clinical and magnetic resonance imaging study of the vascular agent NGR-hTNF in patients with advanced cancers (European Organization for Research and Treatment of Cancer Study 16041).

    Laarhoven, V., Fiedler, W., Fiedler, W., Desar, I. M. E., Asten, V., Jack, J. A., Marréaud, S., Lacombe, D., Govaerts, A-S., Bogaerts, J., Lasch, P., Timmer-Bonte, J. N. H., Lambiase, A., Bordignon, C., Punt, C. J. A., Heerschap, A., Herpen, V. & Carla, M. L., 2010, In: CLIN CANCER RES. 16, 4, p. 1315-1323 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  34. 2009

  35. Antimyeloangiogenic therapy for cancer by inhibiting PlGF.

    Loges, S., Schmidt, T. & Carmeliet, P., 2009, In: CLIN CANCER RES. 15, 11, p. 3648-3653 11.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  36. A simple and accurate model for prediction of cancer-specific mortality in patients treated with surgery for primary penile squamous cell carcinoma.

    Zini, L., Cloutier, V., Isbarn, H., Perrotte, P., Capitanio, U., Jeldres, C., Shariat, S. F., Saad, F., Arjane, P., Duclos, A., Lattouf, J-B., Montorsi, F. & Karakiewicz, P. I., 2009, In: CLIN CANCER RES. 15, 3, p. 1013-1018 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  37. Cell-free tumor DNA in blood plasma as a marker for circulating tumor cells in prostate cancer.

    Schwarzenbach, H., Alix-Panabières, C., Müller, I., Letang, N., Vendrell, J-P., Rebillard, X. & Pantel, K., 2009, In: CLIN CANCER RES. 15, 3, p. 1032-1038 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  38. Genomic profiles associated with early micrometastasis in lung cancer: relevance of 4q deletion.

    Wrage, M., Ruosaari, S., Eijk, P. P., Kaifi, J., Hollmén, J., Yekebas, E. F., Izbicki, J. R., Brakenhoff, R. H., Streichert, T., Riethdorf, S., Glatzel, M., Ylstra, B., Pantel, K. & Wikman, H., 2009, In: CLIN CANCER RES. 15, 5, p. 1566-1574 5.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  39. Longitudinal analysis and prognostic effect of cancer-testis antigen expression in multiple myeloma.

    Atanackovic, D., Luetkens, T., Hildebrandt, Y., Arfsten, J., Bartels, K., Horn, C., Stahl, T., Cao, Y., Zander, A. R., Bokemeyer, C. & Kröger, N., 2009, In: CLIN CANCER RES. 15, 4, p. 1343-1352 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  40. Molecular alterations at 9q33.1 and polyploidy in asbestos-related lung cancer.

    Nymark, P., Kettunen, E., Aavikko, M., Ruosaari, S., Kuosma, E., Vanhala, E., Salmenkivi, K., Pirinen, R., Karjalainen, A., Knuutila, S., Wikman, H. & Anttila, S., 2009, In: CLIN CANCER RES. 15, 2, p. 468-475 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  41. Survivin as a prognostic marker for urothelial carcinoma of the bladder: a multicenter external validation study.

    Shariat, S. F., Karakiewicz, P. I., Godoy, G., Karam, J. A., Ashfaq, R., Fradet, Y., Isbarn, H., Montorsi, F., Jeldres, C., Bastian, P. J., Nielsen, M. E., Müller, S. C., Sagalowsky, A. I. & Lotan, Y., 2009, In: CLIN CANCER RES. 15, 22, p. 7012-7019 22.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  42. 2008

  43. Loss of nuclear p27 expression and its prognostic role in relation to cyclin E and p53 mutation in gastroenteropancreatic neuroendocrine tumors

    Grabowski, P., Schrader, J., Wagner, J., Hörsch, D., Arnold, R., Arnold, C. N., Georgieva, I., Stein, H., Zeitz, M., Daniel, P. T. & Sturm, I., 15.11.2008, In: CLIN CANCER RES. 14, 22, p. 7378-84 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  44. Circulating tumor cells and bone marrow micrometastasis.

    Alix-Panabières, C., Riethdorf, S. & Pantel, K., 2008, In: CLIN CANCER RES. 14, 16, p. 5013-5021 16.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  45. Distinct subcellular expression patterns of neutral endopeptidase (CD10) in prostate cancer predict diverging clinical courses in surgically treated patients.

    Fleischmann, A., Schlomm, T., Huland, H., Köllermann, J., Simon, P., Mirlacher, M., Salomon, G., Chun, F., Steuber, T., Simon, R., Sauter, G., Graefen, M. & Erbersdobler, A., 2008, In: CLIN CANCER RES. 14, 23, p. 7838-7842 23.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  46. High-resolution DNA copy number profiling of malignant peripheral nerve sheath tumors using targeted microarray-based comparative genomic hybridization.

    Mantripragada, K. K., Spurlock, G., Kluwe, L., Chuzhanova, N., Ferner, R. E., Frayling, I. M., Dumanski, J. P., Guha, A., Mautner, V. F. & Upadhyaya, M., 2008, In: CLIN CANCER RES. 14, 4, p. 1015-1024 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  47. Improved prediction of disease relapse after radical prostatectomy through a panel of preoperative blood-based biomarkers.

    Shariat, S. F., Karam, J. A., Walz, J., Roehrborn, C. G., Montorsi, F., Margulis, V., Saad, F., Slawin, K. M. & Karakiewicz, P. I., 2008, In: CLIN CANCER RES. 14, 12, p. 3785-3791 12.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  48. Inhibition of glioblastoma growth in a highly invasive nude mouse model can be achieved by targeting epidermal growth factor receptor but not vascular endothelial growth factor receptor-2.

    Martens, T., Laabs, Y., Günther, H., Kemming, D., Zhu, Z., Witte, L., Hagel, C., Westphal, M. & Lamszus, K., 2008, In: CLIN CANCER RES. 14, 17, p. 5447-5458 17.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  49. Targeting the phosphoinositide 3-kinase isoform p110delta impairs growth and survival in neuroblastoma cells.

    Boller, D., Schramm, A., Doepfner, K. T., Shalaby, T., von Bueren, A., André, O., Eggert, A., Grotzer, M. A. & Arcaro, A., 2008, In: CLIN CANCER RES. 14, 4, p. 1172-1181 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  50. 2007

  51. Effective relief of malignant ascites in patients with advanced ovarian cancer by a trifunctional anti-EpCAM x anti-CD3 antibody: a phase I/II study

    Burges, A., Wimberger, P., Kümper, C., Gorbounova, V., Sommer, H., Schmalfeldt, B., Pfisterer, J., Lichinitser, M., Makhson, A., Moiseyenko, V., Lahr, A., Schulze, E., Jäger, M., Ströhlein, M. A., Heiss, M. M., Gottwald, T., Lindhofer, H. & Kimmig, R., 01.07.2007, In: CLIN CANCER RES. 13, 13, p. 3899-905 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  52. Primary tumor levels of human tissue kallikreins affect surgical success and survival in ovarian cancer patients

    Dorn, J., Schmitt, M., Kates, R., Schmalfeldt, B., Kiechle, M., Scorilas, A., Diamandis, E. P. & Harbeck, N., 15.03.2007, In: CLIN CANCER RES. 13, 6, p. 1742-8 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  53. Clinical significance of epidermal growth factor receptor protein overexpression and gene copy number gains in prostate cancer.

    Schlomm, T., Kirstein, P., Iwers, L., Daniel, B., Steuber, T., Walz, J., Chun, F., Haese, A., Köllermann, J., Graefen, M., Huland, H., Sauter, G., Simon, R. & Erbersdobler, A., 2007, In: CLIN CANCER RES. 13(22 Pt 1), p. 6579-6584

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  54. Combined 1p/19q loss in oligodendroglial tumors: predictive or prognostic biomarker?

    Weller, M., Berger, H., Hartmann, C., Schramm, J., Westphal, M., Simon, M., Goldbrunner, R., Krex, D., Steinbach, J. P., Ostertag, C. B., Loeffler, M., Pietsch, T. & von Deimling, A., 2007, In: CLIN CANCER RES. 13, 23, p. 6933-6937 23.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  55. Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system.

    Riethdorf, S., Fritsche, H., Müller, V., Rau, T., Schindlbeck, C., Rack, B., Janni, W., Coith, C., Beck, K., Jänicke, F., Jackson, S., Gornet, T., Cristofanilli, M. & Pantel, K., 2007, In: CLIN CANCER RES. 13, 3, p. 920-928 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  56. Detection of MAGE-A transcripts in bone marrow is an independent prognostic factor in operable non-small-cell lung cancer.

    Sienel, W., Mecklenburg, I., Dango, S., Ehrhardt, P., Kirschbaum, A., Passlick, B. & Pantel, K., 2007, In: CLIN CANCER RES. 13, 13, p. 3840-3847 13.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  57. Determination of microvessel density by quantitative real-time PCR in esophageal cancer: correlation with histologic methods, angiogenic growth factor expression, and lymph node metastasis.

    Loges, S., Clausen, H., Reichelt, U., Bubenheim, M., Erbersdobler, A., Schurr, P., Yekebas, E. F., Schuch, G., Izbicki, J. R., Pantel, K., Bokemeyer, C. & Fiedler, W., 2007, In: CLIN CANCER RES. 13, 1, p. 76-80 1.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  58. Epidermal growth factor receptor expression in high-grade osteosarcomas is associated with a good clinical outcome.

    Kersting, C., Gebert, C., Agelopoulos, K., Schmidt, H., Diest, V., Paul, J., Juergens, H., Winkelmann, W., Kevric, M., Brandt, B., Brandt, B., Bielack, S. & Buerger, H., 2007, In: CLIN CANCER RES. 13, 10, p. 2998-3005 10.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Previous 1 2 3 Next